Hepatitis Clinical Trials in San Antonio

Showing 221-240 of 249 trials

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

NCT00926614

The aim of the study will be to determine if an insulin sensitizing thiazolidinedione plus a lipid lowering agent (statin) improves sustained virologic response rates in patients who have previously not responded or relapsed on standard pegylated interferon and ribavirin therapy.

Hepatitis c

Brooke Army Medical Center20 participantsStarted Sep 2008

San Antonio, Texas, United States

COMPLETEDPhase 2< 1 mile

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

NCT00863239

The purpose of the study was to assess in subjects with chronic hepatitis C (treatment-naïve, genotype 1) receiving weight-based doses of ribavirin the virologic response to 3 dose levels of Locteron™, dosed every 2 weeks, in comparison with PEG-Intron™ dosed weekly.

Hepatitis C, Chronic

Biolex Therapeutics, Inc.116 participantsStarted Mar 2009

Chula Vista, California, United States • Oceanside, California, United States • San Diego, California, United States +21 more locations

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Hepatitis Trials in Other Cities

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus

Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders

Study of CTS-1027 in Hepatitis C Patients

Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9

Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

Epidemiological Study in Children and Adolescents With Chronic Hepatitis B

Other Conditions in San Antonio